Rigel Pharmaceuticals
RIGL
#6817
Rank
HK$5.85 B
Marketcap
HK$310.87
Share price
-13.26%
Change (1 day)
15.70%
Change (1 year)

EPS for Rigel Pharmaceuticals (RIGL)

EPS in 2023 (TTM): -HK$1.73

According to Rigel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$138.54. In 2022 the company made an earnings per share (EPS) of -HK$2.67 a decrease over its 2021 EPS that were of -HK$0.78.

EPS history for Rigel Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$1.73-35.22%
2022-HK$2.67240%
2021-HK$0.78-37.5%
2020-HK$1.25-60%
2019-HK$3.14-11.11%
2018-HK$3.53-26.23%
2017-HK$4.78-17.57%
2016-HK$5.8025.42%
2015-HK$4.63-42.72%
2014-HK$8.081.98%
2013-HK$7.92-24.06%
2012-HK$10.43-4.32%
2011-HK$10.90-290.41%
2010HK$5.72-126.64%
2009-HK$21.48-25.14%
2008-HK$28.7041.86%
2007-HK$20.2370.86%
2006-HK$11.84-27.4%
2005-HK$16.31-33.33%
2004-HK$24.46-37.73%
2003-HK$39.28-31.83%
2002-HK$57.62-63.55%
2001-HK$158.08-96.43%
2000-HK$4,432

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
HK$127.17-8.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$52.37-62.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-HK$2.98-102.15%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
-HK$14.82-110.70%๐Ÿ‡บ๐Ÿ‡ธ USA